glp-1 receptor list Agonists List: Complete Guide to Drugs, Uses, and Side Effects (2026) GLP-1 Receptor Agonists: A Promising

How adjunctive therapies became untouchable in type 1 diabetes Despite its approval by the EMA, just a few years later, Forxiga was quietly withdrawn from the European market as a medicine for type 1 diabetes

Unleash Your Potential with High-Potency Liquid L-Carnitine

When you get that diagnosis, sometimes you're like, of course, duh, Oh my God, how did I not know this

Companies like Wegovy have been experimenting with subscription-style pricing models

PI3K/Akt/mTOR and MAPK/ERK Pathway Activation In research settings, IGF-1 LR3 activates the PI3K/Akt pathway (involved in survival, glucose metabolism, and protein synthesis), the RAS/MAPK pathway (regulating growth and differentiation), the mTOR pathway (governing anabolic protein synthesis signalling), and IRS-1/2 cross-talk with insulin receptor signalling the full complement of IGF-1R-mediated downstream effects

In this study, we aimed to assess the risk of SIS in new users of GLP-1RA to treat type 2 diabetes mellitus in individuals with obesity, when compared with new users of sodium-glucose cotransporter 2 inhibitors (SGLT-2i)